Vitamin E status in children with cystic fibrosis and pancreatic insufficiency.
Vitamin E status was compared in 69 children (7.0-10.0 years) with cystic fibrosis and pancreatic with the National Health and Nutrition Examination Survey III sample (6.0-11.9 years). With median vitamin E intakes of 6 mg/day (dietary) and 224 mg/day (supplemental), children with cystic fibrosis had higher serum alpha-tocopherol:cholesterol ratios, higher alpha-tocopherol, and lower cholesterol levels than in the National Health and Nutrition Examination Survey.
Huang
Shirley H
SH
Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-4399, USA.
Schall
Joan I
JI
Zemel
Babette S
BS
Stallings
Virginia A
VA
D002648:Child; D002784:Cholesterol / Q000097:blood; D003430:Cross-Sectional Studies; D003550:Cystic Fibrosis / Q000097:blood* / Q000188:drug therapy; D019587:Dietary Supplements; D010188:Exocrine Pancreatic Insufficiency / Q000097:blood* / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D014481:United States; D014810:Vitamin E / Q000097:blood* / Q000627:therapeutic use; D014811:Vitamin E Deficiency / Q000517:prevention & control*; D024502:alpha-Tocopherol / Q000097:blood
D014810:Vitamin E; D002784:Cholesterol; D024502:alpha-Tocopherol